Safety and Outcome Measures of First-in-Human Intraperitoneal alpha Radioimmunotherapy With 212Pb-TCMC-Trastuzumab - Meredith, RF; Torgue, JJ; Rozgaja, TA; Banaga, EP; Bunch, PW; Alvarez, RD (Am J Clin Oncol, 2018)
et al.